Purpose: to award task order 75N95020F00002 (GLP interaction safety studies in rats and dogs) under IDIQ no. HHSN271201800019I.
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,199,035
Award facts
- Opportunity
-
- Toxicological Evaluations of Potential Medications Pre-Solicitation · Posted Dec 4, 2017
- Contract value 100% obligated
- $1,199,034.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$57,009 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Original award | $1,256,044 |
About this award
Sri International has been awarded Task Order 75N95020F00002 under the National Institute on Drug Abuse (NIDA) Indefinite Delivery/Indefinite Quantity (IDIQ) contract HHSN271201800019I to conduct Good Laboratory Practice (GLP) interaction safety studies in rats and dogs. This task order, valued at $1.2M, supports NIDA's broader program of toxicological evaluations of potential medications and was awarded on September 14, 2020, with a completion date of September 13, 2022. The work will be performed at Sri International's facility in Menlo Park, California under a cost-plus-fixed-fee contract type. No small business set-aside was used for this procurement.
This task order represents continued engagement by NIDA with Sri International's established preclinical research capabilities. Sri International, a nonprofit research and development organization headquartered in Menlo Park, holds multiple IDIQ vehicles with the National Institutes of Health and other federal agencies focused on safety evaluation and toxicology studies. The GLP studies under this task order support the evaluation of investigational drug candidates by providing rigorous safety and interaction data in animal models, which is a critical component of NIDA's mission to advance the development of medications for drug abuse and addiction treatment.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on September 14, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $1,199,035 on 75N95020F00002.
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under 75N95018G00019, a basic ordering agreement.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award